Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Tetratherix Ltd (TTX) - Total Liabilities
Latest total liabilities as of June 2025: AU$4.59 Million AUD
Based on the latest financial reports, Tetratherix Ltd (TTX) has total liabilities worth AU$4.59 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tetratherix Ltd - Total Liabilities Trend (2023–2025)
This chart illustrates how Tetratherix Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tetratherix Ltd Competitors by Total Liabilities
The table below lists competitors of Tetratherix Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sino Tactful Co Ltd
TWO:5481
|
Taiwan | NT$362.13 Million |
|
Nexstim Oyj
HE:NXTMH
|
Finland | €9.17 Million |
|
Renaissance Global Limited
NSE:RGL
|
India | ₹9.95 Billion |
|
MEB Corp. PCL
BK:MEB
|
Thailand | ฿276.22 Million |
|
Kafein Yazilim
IS:KFEIN
|
Turkey | TL393.08 Million |
|
Caladrius Biosciences Inc.
LSE:0HS8
|
UK | $3.87 Million |
|
Vente Unique.com
PA:ALVU
|
France | €52.70 Million |
|
Nyrada Inc
AU:NYR
|
Australia | AU$548.97K |
Liability Composition Analysis (2023–2025)
This chart breaks down Tetratherix Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tetratherix Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tetratherix Ltd (2023–2025)
The table below shows the annual total liabilities of Tetratherix Ltd from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$4.59 Million | -43.95% |
| 2024-06-30 | AU$8.18 Million | +37.50% |
| 2023-06-30 | AU$5.95 Million | -- |